MDXHEALTH SA Inactive Instrument
MDxHealth SA Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the MDxHealth's Firs...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Companyâs tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Calendar
2024-05-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +45.66% | 40.65B | |
| -10.72% | 27.12B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
